# Bipartisan resistance prompts withdrawal of Overton’s FDA nomination before vote

- URL: https://talkfuse.com/story/white-house-withdraws-heidi-overtons-fda-nomination-after-trump-pick-received-bipartisan-pushback/
- Published: 2026-11-18T04:05:33+00:00
- Updated: 2026-11-18T10:32:45+00:00
- Original publisher: New York Post (publisher lean: Right)
- Original article: https://nypost.com/2026/11/17/us-news/white-house-withdraws-heidi-overtons-fda-bid-after-nominee-received-bipartisan-pushback/
- Topics: World

## Key points

- The White House withdrew Overton’s FDA nomination before a Senate committee vote.
- Bipartisan concerns left her without enough support.
- Senator Roger Marshall is reportedly a possible replacement.

## Summary

The White House withdrew Heidi Overton’s nomination to lead the Food and Drug Administration on the eve of a Senate committee vote, after she failed to secure enough support. The decision followed bipartisan resistance and leaves the administration to choose a new nominee for the agency.

Overton, a physician and deputy director of the White House Domestic Policy Council, was nominated in August. Critics raised concerns about her alleged tobacco industry ties, support for vaping, lack of managerial experience and role in efforts to change childhood vaccine guidelines; her past criticism of the abortion pill mifepristone also drew scrutiny. At her hearing, she acknowledged the drug was FDA-approved and said she would follow statutory safety and efficacy standards. Senator Roger Marshall is reportedly being considered for the vacancy.

## Coverage

- [New York Post: Bipartisan resistance prompts withdrawal of Overton’s FDA nomination before vote](https://nypost.com/2026/11/17/us-news/white-house-withdraws-heidi-overtons-fda-bid-after-nominee-received-bipartisan-pushback/)
- [The Guardian: White House withdraws nomination of Heidi Overton to lead FDA](https://www.theguardian.com/us-news/2026/nov/17/white-house-withdraws-heidi-overton-fda)

---
Summarised by TalkFuse (https://talkfuse.com/). Quote the original publisher for the reporting and link this page for the summary and discussion.
